ABBV AbbVie PE ratio, current and historical analysis
As at Dec 20, 2024, the ABBV stock has a PE ratio of 60.97. This is based on the current EPS of $2.88 and the stock price of $175.58 per share. An increase of 3.1% has been seen in the P/E ratio compared to the average of 59.1 of the last 4 quarters.
ABBV PE ratio history
The mean historical PE ratio of AbbVie over the last ten years is 29.82. The current 60.97 PE ratio is 104% above the historical average. Over the past ten years, ABBV's PE ratio was at its highest in the Sep 2024 quarter at 68.57, with a price of $197.48 and an EPS of $2.88. The Mar 2020 quarter recorded the bottom point at 13.44, with a price of $76.19 and an EPS of $5.67.
AbbVie PE ratio by year
Maximum annual increase: 187.98% in 2014
Maximum annual decrease: -68.09% in 2015
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 56.77 | 133.62% |
| 2022 | 24.3 | 16.27% |
| 2021 | 20.9 | -46.75% |
| 2020 | 39.25 | 134.89% |
| 2019 | 16.71 | -33.48% |
| 2018 | 25.12 | -14.03% |
| 2017 | 29.22 | 70.28% |
| 2016 | 17.16 | -8.77% |
| 2015 | 18.81 | -68.09% |
| 2014 | 58.95 | 187.98% |
ABBV average PE ratio chart
ABBV's current P/E ratio is above the 3, 5 and 10-year historical averages.
ABBV PE vs peers
ABBV's PE ratio is lower than its peer stocks LLY and GILD, but it is greater than AZN's and PFE's. AbbVie's current PE ratio of 60.97 is above the average of its peers, which is 38.37.
| Stock name | PE ratio | Market cap |
|---|---|---|
| BIIB Biogen Inc | 13.18 | $21.34B |
| AZN Astrazeneca plc | 31.27 | $202.59B |
| AMGN Amgen Inc | 33.38 | $141.58B |
| PFE Pfizer Inc | 34.68 | $149.38B |
| NBIX Neurocrine Biosciences Inc | 35.08 | $13.71B |
| ABBV AbbVie Inc | 60.97 | $310.27B |
| LLY ELI LILLY & Co | 82.64 | $728.85B |
| GILD Gilead Sciences Inc | 925.7 | $115.37B |
| BMY Bristol Myers Squibb Co | N/A | $116.28B |
Frequently asked questions
What is AbbVie's PE ratio?
As of Dec 20, 2024, ABBV stock has a price to earnings ratio of 60.97.
What is the 3-year average PE ratio for AbbVie (ABBV)?
The average PE ratio for ABBV stock over the past 3 years is 37.51.
What is the 5-year average PE ratio for AbbVie (ABBV)?
The average PE ratio for ABBV stock over the past 5 years is 32.71.
What is the highest PE ratio for ABBV?
Over the last ten years, the quarterly PE ratio reached a historic high of 68.57 in the Sep 2024 quarter.
How does the current PE ratio for ABBV compare to its historical average?
ABBV's current price to earnings ratio is 104% above its 10-year historical average.
How is ABBV's PE ratio calculated (AbbVie PE ratio formula)?
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Dec 20, 2024), AbbVie's stock price is $175.58. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $2.88. Therefore, AbbVie's P/E ratio for today is 60.97. PE RATIO(60.97) = STOCK PRICE($175.58) / TTM EPS($2.88)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.